60% off Profit Pro - Limited Time Offer!
40.09MUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
IL0004960188
CUSIP
19516R107
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
2.48
Dividend Share
-
Dividend Yield
-
Earnings Share
-1.53
Wall Street Target Price
12.5
EPS Estimate Current Year
0
EPS Estimate Next Year
0
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
689,000
Gross Profit TTM
13,636,000
EBITDA
-17,308,000
Profit Margin
0.00%
Return On Assets TTM
-33.77%
Return On Equity TTM
-61.55%
Revenue Per Share TTM
0.06
Qtly Revenue Growth YOY
-97.60%
Diluted Eps TTM
-1.53
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
15
Price Sales TTM
58.1869
Price Book MRQ
2.3697
Enterprise Value Revenue
43
Enterprise Value EBITDA
-5
88.70
1.04%411.98
1.00%632.04
0.33%630.00
0.00%173.50
0.00%198.28
0.00%99.02
-0.96%113.00
-0.80%241.92
-0.63%714.20
-0.04%